Investor Contact: Steve Kunszabo Organovo Holdings, Inc.+1 (858) email@example.comPress Contact:Jessica YinglingLittle Dog Communications+1 (858) firstname.lastname@example.org
The companies inked a $250 million deal on Friday that could be worth up to $2 billion, thanks to milestone payments.
Pacira Pharmaceuticals, Clearside Biomedical and Organovo Holdings are among the premarket biotech movers on Wednesday.
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.
Organovo (ONVO) said on Thursday that it would sell 9 million shares of common stock at $2.75 per share in a public offering.